Avoro Capital Advisors LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
09:08 am
Purchase
2023-12-3113GSPYRE THERAPEUTICS, INC
SYRE
Avoro Capital Advisors LLC2,125,597
5.900%
2,125,597increase
(New Position)
Filing
History
2024-02-14
09:07 am
Purchase
2023-12-3113GSTRUCTURE THERAPEUTICS INC SPO
GPCR
Avoro Capital Advisors LLC6,999,999
5.000%
6,999,999increase
(New Position)
Filing
History
2024-02-14
09:05 am
Sale
2023-12-3113GUNITED THERAPEUTICS CORP
UTHR
Avoro Capital Advisors LLC2,858,888
6.100%
-6,112decrease
(-0.21%)
Filing
History
2024-02-14
09:04 am
Unchanged
2023-12-3113GMARINUS PHARMACEUTICALS INC
MRNS
Avoro Capital Advisors LLC3,150,000
5.800%
0
(Unchanged)
Filing
History
2024-02-14
09:02 am
Purchase
2023-12-3113GBIOCRYST PHARMACEUTICALS INC
BCRX
Avoro Capital Advisors LLC13,050,000
6.400%
13,050,000increase
(New Position)
Filing
History
2024-02-14
09:00 am
Sale
2023-12-3113GIO BIOTECH INC
IOBTQ
Avoro Capital Advisors LLC0
0.000%
-2,055,883decrease
(Position Closed)
Filing
History
2023-02-14
09:41 am
Sale
2022-12-3113GXENON PHARMACEUTICALS INC
XENE
Avoro Capital Advisors LLC4,900,000
7.800%
-85,000decrease
(-1.71%)
Filing
History
2023-02-14
09:40 am
Purchase
2022-12-3113GMONTE ROSA THERAPEUTICS INC CO
GLUE
Avoro Capital Advisors LLC4,325,000
8.900%
1,013,566increase
(+30.61%)
Filing
History
2023-02-14
09:38 am
Purchase
2022-12-3113GMERSANA THERAPEUTICS INC
MRSN
Avoro Capital Advisors LLC302,000
7.600%
30,000increase
(+11.03%)
Filing
History
2023-02-14
09:37 am
Sale
2022-12-3113GIVERIC BIO INC
ISEE
Avoro Capital Advisors LLC6,750,000
4.960%
-500,000decrease
(-6.90%)
Filing
History
2023-02-14
09:37 am
Purchase
2022-12-3113GMADRIGAL PHARMACEUTICALS INC C
MDGL
Avoro Capital Advisors LLC1,660,000
9.700%
235,000increase
(+16.49%)
Filing
History
2023-02-14
09:37 am
Purchase
2022-12-3113GKYMERA THERAPEUTICS INC
KYMR
Avoro Capital Advisors LLC3,850,000
7.000%
3,850,000increase
(New Position)
Filing
History
2023-02-14
09:36 am
Purchase
2022-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
Avoro Capital Advisors LLC10,625,000
9.600%
2,069,445increase
(+24.19%)
Filing
History
2023-02-14
09:36 am
Sale
2022-12-3113GMARINUS PHARMACEUTICALS INC
MRNS
Avoro Capital Advisors LLC3,150,000
6.300%
-85,000decrease
(-2.63%)
Filing
History
2023-02-14
09:35 am
Purchase
2022-12-3113GAMICUS THERAPEUTICS INC
FOLD
Avoro Capital Advisors LLC26,800,000
9.500%
8,300,000increase
(+44.86%)
Filing
History
2023-02-14
09:35 am
Purchase
2022-12-3113GPMV PHARMACEUTICALS INC
PMVP
Avoro Capital Advisors LLC3,060,000
6.700%
1,595,000increase
(+108.87%)
Filing
History
2023-02-14
09:34 am
Sale
2022-12-3113GUNITED THERAPEUTICS CORP
UTHR
Avoro Capital Advisors LLC2,865,000
6.300%
-170,000decrease
(-5.60%)
Filing
History
2023-02-14
09:34 am
Purchase
2022-12-3113GMIRATI THERAPEUTICS INC
MRTX
Avoro Capital Advisors LLC5,555,555
9.600%
480,555increase
(+9.47%)
Filing
History
2023-02-14
09:33 am
Purchase
2022-12-3113GKRYSTAL BIOTECH INC
KRYS
Avoro Capital Advisors LLC1,410,000
5.500%
1,410,000increase
(New Position)
Filing
History
2023-02-14
09:33 am
Purchase
2022-12-3113GASCENDIS PHARMA A/S SPONSORED
ASND
Avoro Capital Advisors LLC3,100,000
5.400%
3,100,000increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next